Astellas Gene Therapies to Close Biomanufacturing Facility, Affecting About 100 Employees

Astellas Gene Therapies is closing its San Francisco biomanufacturing facility, shifting gene therapy manufacturing to North Carolina, cutting at least 17 employees and affecting dozens more.